SMAD3 and neoplasm: More evidence supporting the tumor-suppressing role of Smad3 comes from experiments with Smad3-deficient mice, where Smad3 deficiency alone is not enough to initiate tumorigenesis, but decreased Smad3 expression augmented the risk of tumorigenesis when associated with alterations in other genes involved in cellular proliferation and apoptosis [33,34].